Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, announces that it has been granted US FDA (Food and Drug Administration) authorization to produce its own active pharmaceutical ingredients (APIs) in order to manufacture drugs for the US market.
Shortly after opening its production plant in 2019, following an inspection by the French National Agency for the Safety of Medicines and Health Products (ANSM), Provepharm was awarded GMP (Good Manufacturing Practice) certification to produce its own active ingredients for European countries. The plant is located at the Ch
